Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2020 | Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study | LANCET ONCOLOGY |